Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Prolactinoma 2Prolactin Deficiency, Isolated 1Hyperprolactinemia 1

Interventions

Cabergoline 6Dopamine Agonists 2ropinirole 1pasireotide 1Tissue Banks 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prolactinoma × Dopamine Agonists × Clear all
NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting
60 enrolled

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

NCT04107480 2020-07-20

PRolaCT - Three Prolactinoma RCTs

Leiden University Medical Center

Phase 4 Unknown
880 enrolled

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡